CLOs on the Move


 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Centerstone

Centerstone is a not-for-profit health system providing mental health and substance use disorder treatments. Services are available nationally through the operation of outpatient clinics, residential programs, the use of telehealth and an inpatient hospital. Centerstone also features specialized programs for the military community, therapeutic foster care, children`s services and employee assistance programs. Centerstone`s Research Institute provides guidance through research and technology, leveraging the best practices for use in all our communities. Centerstone`s Foundation secures philanthropic resources to support the work and mission of delivering care that changes people`s lives.

Green River Regional Mental Health Mental Retardation Board Inc

Green River Regional Mental Health Mental Retardation Board Inc is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sawtooth Surgery Center

Sawtooth Surgery Center is a Twin Falls, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Absolute Resource Solutions

Absolute Resource Solutions is a Flanders, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SynGen

SynGen advances regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with innovative, robust systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.